1-151133151-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030913.6(SEMA6C):āc.2126T>Cā(p.Val709Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000902 in 1,552,398 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030913.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA6C | ENST00000368914.8 | c.2126T>C | p.Val709Ala | missense_variant | 19/19 | 1 | NM_030913.6 | ENSP00000357910.3 | ||
SEMA6C | ENST00000368913.7 | c.2222T>C | p.Val741Ala | missense_variant | 20/20 | 1 | ENSP00000357909.3 | |||
SEMA6C | ENST00000341697.7 | c.2126T>C | p.Val709Ala | missense_variant | 19/19 | 1 | ENSP00000344148.3 | |||
SEMA6C | ENST00000368912.7 | c.2102T>C | p.Val701Ala | missense_variant | 19/19 | 1 | ENSP00000357908.3 |
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150528Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000577 AC: 10AN: 173352Hom.: 0 AF XY: 0.0000307 AC XY: 3AN XY: 97704
GnomAD4 exome AF: 0.00000785 AC: 11AN: 1401870Hom.: 0 Cov.: 33 AF XY: 0.00000574 AC XY: 4AN XY: 696434
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150528Hom.: 0 Cov.: 32 AF XY: 0.0000272 AC XY: 2AN XY: 73498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.2222T>C (p.V741A) alteration is located in exon 20 (coding exon 18) of the SEMA6C gene. This alteration results from a T to C substitution at nucleotide position 2222, causing the valine (V) at amino acid position 741 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at